Krebs cycle disorders constitute a group of rare human diseases which present an amazing complexity considering our current knowledge on the Krebs cycle function and biogenesis. Acting as a turntable of cell metabolism, it is ubiquitously distributed in the organism and its enzyme components encoded by supposedly typical house-keeping genes. However, the investigation of patients presenting specific defects of Krebs cycle enzymes, resulting from deleterious mutations of the considered genes, leads to reconsider this simple envision by revealing organ-specific impairments, mostly affecting neuromuscular system. This often leaves aside organs the metabolism of which strongly depends on mitochondrial energy metabolism as well, such as heart, kidney or liver. Additionally, in some patients, a complex pattern of tissue-specific enzyme defect was also observed. The lack of functional additional copies of Krebs cycle genes suggests that the complex expression pattern should be ascribed to tissue-specific regulations of transcriptional andror translational activities, together with a variable cell adaptability to Krebs cycle functional defects. q 1997 Elsevier Science B.V.
Introduction

Ž
. 1992: 'This pathway i.e. the Krebs cycle is so crucial to the metabolism of living cells that any w x significant defect is incompatible with life' 1 . Accordingly, enzyme defects affecting the Krebs cycle, Ž . also known as the tricarboxylic acid cycle TCAC , were for long considered as highly unlikely. Thus, even the disclosure of a high fumaric aciduria in Ž patients was not sufficient to prompt authors in the . eighties to measure fumarase activity: 'since it is very probable that the concomitant failure of oxidative metabolism associated with the TCAC would have catastrophic physiological and clinical consew x quences' 2 . Ž However, although rare diseases less than 25 . cases reported in the literature , defects affecting one or more of the TCAC enzymes have been now convincingly established. For the sake of comparison, Ž . on 1300 young patients 0-15 yr investigated in our laboratory, we identified 6 cases with a TCAC enzyme defect compared to 220 cases with a respiratory chain enzyme defect. In the three last years, the molecular bases were elucidated in the case of two of tutes the major function of the TCAC. However, it also ensures a central role in the intermediary metabolism through the breakdown of acetyl-CoA and through the interconversion of carbon skeletons Ž . required for several anaplerotic pathways Fig. 1 . Moreover, TCAC should also be considered as a water splitting process generating oxygen for glucose w x oxidation and CO production 6 . Two reactions of tions, namely the combination between acetyl-CoA and oxaloacetate to form citrate and the formation of malate from fumarate. Atmospheric oxygen is only used for the reoxidation of reduced coenzymes by the respiratory chain.
The TCAC is constituted by a series of 8 biochemical reactions that lead to the progressive oxidative decarboxylation of the acetyl CoA, mostly resulting Ž from the activity of the pyruvate dehydrogenase in order to account for the complexity and the variety of the physiological contexts encountered in living cells. TCAC-related enzyme equipment of mitochondria may vary between species, and, in one given species, between organs. Thus mitochondria endowed with matrix malic enzyme can use malate as unique fuel molecule for TCAC running, malate being then used as a source of both pyruvate and oxaloacetate Ž . OAA through the reactions catalysed by the malic enzyme and the malate dehydrogenase respectively w x 7,8 . On the other hand, the unity of the cycle has been questioned and some suggestions have been made that it is actually comprised of 2 independent segments, allowing different fluxes, extending from a-KG to OAA and from OAA to a-KG, respectively w x 9 . Working in close connection with the aspartate-Ž . amino acid transferase AAT, which produces a-KG , these would constitutes 'mini-Krebs cycles' consuming or producing glutamate and aspartate, requiring Ž . only catalytic amounts of OAA or of a-KG Fig. 2 .
The TCAC takes place in the semi-fluid matrix space of the mitochondria where metabolically-related enzymes appear to be associated into metabolons ensuring channelling of substrates through selected w x sets of enzymes 10 . Accordingly, the TCAC enzymes are consistently found in balanced proportions w x in different tissues 11 , suggesting a concerted expression of the genes coding for TCAC enzymes. The semi-fluid state of the matrix also favours a kinetic compartmentation of soluble oxidation cofactors, such w x as nicotinamide adenine dinucleotides 12 , together with the several dehydrogenases.
Citrate synthase, isocitrate and a-KG dehydrogenases are generally considered as important regulatory steps controlling the flux through the entire cycle w x 1 . The pyridine nucleotide redox poise Ž . NADHrNADq , the matrix phosphorylation po-Ž .
2 q tential Pi q ADPrATP ratio and the Ca concentrations act as major regulatory factors controlling several steps of the TCAC. Finally, a wealth of evidences has been provided showing that thyroid hormones and glucocorticoids w x influence the activity of the TCAC cycle 13,14 . On one hand, thyroid hormone-induced increase of mitochondrial Ca 2q and substrate supply would stimulate w x the overall TCAC activity 13 . On the other hand, control of mitochondrial biogenesis by thyroid hormones and glucocorticoids, exerted at both transcriptional and translational levels, would account for broader term effect of hormones on TCAC activity w x 13,14 .
The TCAC enzymes are all nuclearly-encoded. Ž . Most of the nuclear genes 11 on 15 encoding the protein moieties constitutive of the 9 TCAC mitochondrial enzymes have now been localized in man and 9 of the corresponding cDNAs have been cloned Ž . and sequenced Table 1 . Four of the TCAC enzymes possess both a mitochondrial and a cytosolic isoen-Ž . zyme Table 1 . In the particular case of fumarase, both isoenzymes have been shown to be encoded by a single gene, which raises intriguing questions upon the mechanism controlling their sub-cellular distribuw x tion 15 .
Krebs cycle diseases
Few cases of isolated and supposedly primary Krebs cycle disorders have been reported in human. Deficiencies of a-KG dehydrogenase, succinate de-
. hydrogenase SDH and fumarase were reported in 3, Ž . 7 and 14 patients, respectively Table 2 . Beside these specific enzyme defects, enzymes of the TCAC can be affected concurrently with enzymes involved in other metabolic pathways. Thus, a defect of the Ž dihydrolipoamide dehydrogenase the E component 3 . of the 2-ketoacid dehydrogenases characteristically associates a defective activity of the pyruvate and the branched-chain amino acid dehydrogenases together w x with a decreased a-KG dehydrogenase activity 33 . A decrease of both aconitase and SDH has also been reported in one patient presenting with generalized defect of iron-sulfur proteins, including rhodanese, the Rieske protein of the complex III and several subunits of the complex I of the respiratory chain w x 34 .
Among the major clinical features encountered in patients presenting isolated TCAC enzyme defects, neurological impairments -associated or not with muscular involvement -are prominent figures, being Ž . encountered in 19r22 cases 85% , with en-Ž . cephalopathy 11 cases and typical Leigh syndrome Ž . 1 case being reported in 70% of the documented Ž . cases Table 2 . Hypertrophic cardiomyopathy, iso-Ž . Ž lated 1 case or part of a pluritissular disease 4 . cases , has also been reported in 18% of the cases, all of them presenting with a SDH deficiency, except for one case presenting with a-KG dehydrogenase defiw x ciency 17 . Interestingly enough, no cardiac involvement was reported for any of the patients presenting Ž . with a fumarase deficiency Table 2 .
The age of onset of fumarase and a-KG dehydrogenase deficiencies was consistently below 1 y of age, with hypotonia, failure to thrive andror lactic acidosis being frequently first noticed. In contrast, patients with SDH deficiencies were often diagnosed w x after several years of life 19 or even in adulthood w x 20,23 . Onset symptoms associated with SDH deficiencies vary from case to case, among them growth retardation, pulmonary oedema, bronchiolitis, body rigidity or optic atrophy. Although not consistently, the latter onset and the milder outcome noticed for SDH-deficient patients correspond to relatively higher Ž . enzyme residual activities Table 2 .
An abnormal urinary excretion of organic acids was frequently noticed in those patients with TCAC enzyme deficiencies, with occasional peaks of a-KG Ž observed whatever the enzyme deficiency a-KG . dehydrogenase, SDH, or fumarase . Obviously due to the enzyme defect in cases of a-KG dehydrogenase deficiencies, this a-KG excretion might result from the secondary blockade of this enzyme by succinyl CoA in the case of SDH and fumarase deficiencies Ž . see Fig. 1 . The excretion of a-KG is also an indication that at least a segment of the TCAC metabolizes pyruvate. This possibly accounts as well for the inconsistency of the lactic acidosis and the mild, if any, elevation of LrP ratios measured in these patients.
Biochemical, molecular findings and genetics
As mentioned above, while profound defects of Ž fumarase both cytosolic and mitochondrial isoen-. zymes and a-KG dehydrogenase have often been Ž . reported less than 1% in vitro residual activity , only Ž partial SDH defects have been reported more than . 25% in vitro residual activity . Incidentally, it is noteworthy that the profound defects of TCAC enzymes only concern enzymes involved in one of the mini-Krebs cycle suggesting an activation of an in Ž vivo metabolic by-pass allowing cell survival SDH deficiencies are also distinct by their variable tissue-specific expression which was observed in three w x of the cases reported 21,23,24 . This was somewhat surprising considering that the products of the house-keeping TCAC genes are essentially distributed among all human tissues. No functional additional copies of Krebs cycle genes have been reported so far, suggesting that the tissue-specific expression pattern should rather be ascribed to tissue-specific regulations of transcriptional andror translational activities.
Identification of mutations causing TCAC enzyme deficiencies have been now reported for both fuw x w x marase 3,34 and SDH 4 . A mutation in the fumarase cDNA was first reported in two siblings with progressive encephalopathy and fumarase deficiency w x 3 . Both patients were found homozygous for a missense mutation, a G955C transversion, predicting a Glu319Gln substitution in a highly conserved do-( ) Table 2 Clinical, metabolic, biochemical and molecular findings in patients presenting with isolated Krebs cycle enzyme and defects Both first cousin parents were found heterozygous for this substitution. Accordingly, fumarase activity in parent's lymphoblastoid cell lines represented about 50% of mean control activity, in both the mitochondrial and cytosolic compartments. Mutations of the fumarase cDNA were Ž . since reported in six unrelated families Table 2 . A mutation in the succinate flavoprotein subunit cDNA has been reported in two sisters presenting w x with Leigh syndrome and SDH deficiency 3 . Both patients were found homozygous for a Arg544Trp substitution in a highly conserved domain of the SDH cDNA. Both consanguineous parents were found heterozygous for this substitution. Expression of mutant and wild-type SDH Fp cDNAs in enzyme-deficient yeast strain confirmed the pathogenic character of this substitution.
Our present knowledge on the molecular bases of TCAC diseases is restricted to the cases mentioned above.
Recessive inheritance of the mutations was noticed in both of the cases of fumarase and SDH deficienw x cies which have been elucidated 2,3 . The consanguinity of the parents suggests a similar recessive inheritance in the cases of a-KG dehydrogenase and w x in most cases of fumarase deficiencies [16] [17] [18] 34 . Several patients presenting with SDH or fumarase defect and born from unrelated parents have also w x been reported [19] [20] [21] 25, 26, 28, 29 . Nevertheless, the primary nature of these defects remains to be established before assessing other modes of inheritances.
Conclusion
The recent elucidation of the molecular basis of several TCAC enzyme deficiencies definitively establishes the occurrence of isolated and primary TCAC deficiencies in man. This new group of diseases has to be added to other known diseases affecting the oxidative activities of the mitochondria, namely respiratory chain activity and fatty acid b-oxidation. No clinical clue allows to easily distinguish between these different diseases, the patients often presenting with similar neuromuscular impairments. The disclosure of anomalous urinary excretion of specific organic acids should however prompt investigation of TCAC enzyme activities. Noticeably, an excretion of organic acids, particularly of a-KG, is also frequently observed in respiratory chain disorders, but this generally does not specifically concern one unique metabolite.
The investigation of the patients presenting with a TCAC enzyme defect has revealed a surprising complexity, the mechanism of which remains largely to be established. Already, it teaches us that, as previw x ously suggested in animal 9 , the TCAC in human is possibly organized around two distinct cycles, one of which being potentially by-passed in vivo. This probably accounts for the normal respiration and survival of enzyme-deficient cells in culture, as well as for the several-years survival of most of these patients, despite a life-threatening prognosis.
